Amazon (AMZN) Pharmacy Introduces RxPass
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- Moderna shares rise ahead of cancer vaccine trial results
Amazon (AMZN) to face challenges as COVID-fueled growth normalizes
January 24, 2023 10:08 AM ESTTelsey Advisory Group reiterated an Outperform rating on Amazon.com (NASDAQ: AMZN) but cut the price target on the e-commerce company to $125.00 (From $140.00) ahead of its 4Q22 earnings release scheduled for Thursday, February 2nd.
Telsey reduced their 4Q22 and 2023 outlook on the company to reflect a more challenging consumer and corporate spending environment. The company is facing headwinds in the form of a normalizing... More



